Your fast track to the ultramodern lab

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.

Your fast track to the ultramodern lab

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Arrow Right

Your fast track to the ultramodern lab

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.

Your fast track to the ultramodern lab

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Meet the future of pathology
Arrow Right

How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?

Your patient, our priority
Urologidagarna i Malmö, booth #43
Malmö Live
October 5–7, 2022 

Learn more about Inify Laboratories

Watch the video presentation

One out of seven will be diagnosed with prostate cancer

Handling of prostate biopsies makes up an increasing amount of workload for today’s pathology labs. Here, powerful decision support tools – such as Inify Prostate – have the potential to save valuable time for the pathologist, while ensuring a more objective, consistent and accurate evaluation of the biopsies.
PANEL TALK 

Successful first months of laboratory operation: Panel talk Q3 report 2023

Inify’s Q3 report is published and highlights continuous diagnostic operation and very positive feedback from customers. Inify’s CEO Fredrik Palm and Chief Medical Officer Claes Lindh talks about what this means for patients in practice in this panel talk together with Ole Eikeland.
For more panel discussions, please visit our YouTube channel
PANEL TALK 

Inify’s progress: Panel talk Q4 report 2023

Listen to CEO Fredrik Palm and Sales & Marketing Manager Maria Holmberg in this panel talk about the Q4 report 2023, where they discuss how customers have been able to shorten time for result to patients from 21 to 7 days, how word-of-mouth marketing has led to incoming calls plus how AI supports the pathologists making the cancer diagnosis.
For more panel discussions, please visit our YouTube channel

Follow our YouTube channel

Newsletter

Want to join us on our journey?
Let’s talk.